Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · IEX Real-Time Price · USD
+0.080 (4.62%)
Jun 14, 2024, 10:02 AM EDT - Market open

Virax Biolabs Group Market Cap

Virax Biolabs Group has a market cap or net worth of $3.90 million as of June 14, 2024. Its market cap has decreased by -13.41% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $56.87M to $3.90M, a decrease of -93.15%. That is a compound annual growth rate of -75.68%.


DateMarket Cap% Change
Jun 12, 20243.00M-
Jun 11, 20243.00M-14.29%
Jun 10, 20243.50M-2.78%
Jun 7, 20243.60M-
Jun 6, 20243.60M89.47%
Jun 5, 20241.90M-
Jun 4, 20241.90M-
Jun 3, 20241.90M-9.52%
May 31, 20242.10M5.00%
May 30, 20242.00M17.65%
May 29, 20241.70M6.25%
May 28, 20241.60M-
May 24, 20241.60M6.67%
May 23, 20241.50M-
May 22, 20241.50M7.14%
May 21, 20241.40M-6.67%
May 20, 20241.50M-
May 17, 20241.50M7.14%
May 16, 20241.40M-
May 15, 20241.40M-
May 14, 20241.40M-
May 13, 20241.40M-
May 10, 20241.40M16.67%
May 9, 20241.20M-14.29%
May 8, 20241.40M7.69%
View and export this data all the way back to 2022. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition